Brain Cancer Therapeutics Market Size, Share & Industry Analysis, By Type(Gliomas, Meningiomas, Pituitary Adenomas, Vestibular Schwannomas, Neuroectodermal Tumors), By Treatment (Chemotherapy, Immunotherapy, Targeted Drug Therapy, Radiation Therapy, Others) and Regional Forecast, 2024-2032

Region :Global | Report ID: FBI101840 | Status : Ongoing

KEY MARKET INSIGHTS

In May 2019, Australian company Kazia Therapeutics collaborated with the “Alliance for Clinical Trials in Oncology Foundation” on clinical trials for metastatic brain cancer treatment. Brain cancer is referred as the growth of abnormal cells in the brain. Some are non-cancerous or benign, and some are cancerous or malignant. The exact cause of brain cancer is not known; however, some of the identified factors that may increase the risk of brain cancer are exposure to ionizing radiation or the family history of brain tumour. The signs and symptoms of a brain tumour vary greatly and depend on the brain tumour’s size, location and rate of growth. The general symptoms include headache, gradual loss of sensation, difficulty in balance, speech difficulties, hearing problems. The treatment for brain cancer depends upon the type, size and location of the tumour. The main treatments are surgery, radiotherapy, chemotherapy, radiosurgery, and carmustine implants.

Key Market Driver -

Rising prevalence of brain cancer, growing research activities for developing novel treatments

Key Market Restraint -

High costs and side effects associated with existing treatment options

Factors such as the rising prevalence of brain cancer, growing research activities for developing novel treatments and increased government funding for brain cancer treatment research are expected to drive the growth of the global brain cancer therapeutics market during the forecast period. However, the high cost of the therapeutics, adverse side effects associated with cancer treatment medications, are projected to hamper the market growth during the forecast period.

Key Players Covered:

Some of the major companies that are present in the brain cancer therapeutics market include F. Hoffmann-La Roche AG, Merck and Co. Inc., Novartis AG, Eisai Co. Ltd., Pfizer Inc., Bayer AG, and others.

Key Insights

Prevalence of brain cancer for key countries or key regions

New product launches in brain cancer therapeutics market

Technological advancements in global brain cancer therapeutics market

Recent industry developments such as partnerships, mergers, and acquisitions

Regional Analysis:

North America is projected to dominate the global brain cancer therapeutics market over the forecast period, followed by Europe. The dominance of North America is mainly attributed to the developed healthcare infrastructure, rising awareness regarding the adoption of advanced technologies among the patients and the presence of a large patient population. On the other hand, Asia Pacific is expected to witness the fastest growth during the forecast period.

To gain extensive insights into the market, Request for Customization

Increasing accessibility to healthcare facilities, evolving healthcare infrastructure and the large population suffering from brain cancer are the factors projected to drive the growth of the market in the Asia Pacific region. Latin America and Middle East America are also expected to have substantial growth in the brain cancer therapeutics market during the forecast period.

Segmentation

ATTRIBUTE	DETAILS
By Type	Gliomas Meningiomas Pituitary Adenomas Vestibular Schwannomas Neuroectodermal Tumors
By Treatment	Chemotherapy Immunotherapy Targeted Drug Therapy Radiation Therapy Others
By Geography	North America (USA and Canada) Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe) Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific) Latin America (Brazil, Mexico and Rest of Latin America) Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Brain Cancer Therapeutics Industry Developments

In April 2019, Mateon Therapeutics, Inc. merged with Oncotelic Inc. to focus on pipeline of TGF-β RNA therapeutics for late stage cancers, including gliomas and melanoma.

In May 2019, China Anti-Cancer Association launched Optune, a cancer therapy that uses electric fields to disrupt cell division which inhibits tumour growth.

In November 2018, Department of Radiation Oncology, Germany launched intensity-modulated radiotherapy (IMRT) which allows the delivery of higher radiation doses to the target volume and at the same time reduces the risk of toxicity to normal tissues as compared with conventional 3D conformal radiotherapy (3D-CRT).

REQUEST SAMPLE

SPEAK TO ANALYST

PUBLISHING STATUS: Ongoing
BASE YEAR: 2023
HISTORICAL DATA: 2019-2022

Multi-report Purchase Plan

Healthcare Clients

Client Testimonials

“We are quite happy with the methodology you outlined. We really appreciate the time your team has spent on this project, and the efforts of your team to answer our questions.”

- One of the largest & renowned medical research centers based in the U.S. on a report on the U.S. NIPT Market.

“Thanks a million. The report looks great!”

- Feedback from a consultant on a report on the U.S. Beef Market.

“Thanks for the excellent report and the insights regarding the lactose market.”

- Brazil based company specializing in production of protein ingredients.

“I liked the report; would it be possible to send me the PPT version as I want to use a few slides in an internal presentation that I am preparing.”

- Global Digital Services Agency on a report on the Global Luxury Goods Market.

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry

Get in Touch with Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )
+91 744 740 1245 (APAC)
[email protected]